Association between genetic variants in the Coenzyme Q 10metabolism and Coenzyme Q10status in humans

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Fischer, Alexandra ^a   Schmelzer, Constance ^a   Rimbach, Gerald ^a   Niklowitz, Petra ^b   Menke, Thomas ^b   Döring, Frank ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960557093     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-245     Document Type: Article

References (38)

1. Metabolism and function of coenzyme Q. Turunen M, Olsson J, Dallner G, Biochim Biophys Acta 2004 1660 1-2 171 199 10.1016/j.bbamem.2003.11.012 14757233 (Pubitemid 38125244)
2. Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Kwong LK, Kamzalov S, Rebrin I, Bayne AC, Jana CK, Morris P, Forster MJ, Sohal RS, Free Radic Biol Med 2002 33 5 627 638 10.1016/S0891-5849(02)00916-4 12208349 (Pubitemid 35245835)
3. Coenzyme Q - biosynthesis and functions. Bentinger M, Tekle M, Dallner G, Biochem Biophys Res Commun 396 1 74 79
4. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Groneberg DA, Kindermann B, Althammer M, Klapper M, Vormann J, Littarru GP, Doring F, Int J Biochem Cell Biol 2005 37 6 1208 1218 10.1016/j.biocel.2004.11.017 15778085 (Pubitemid 40381197)
5. Identification of LPS-inducible genes downregulated by ubiquinone in human THP-1 monocytes. Schmelzer C, Doring F, Biofactors 2010 36 3 222 228 10.1002/biof.93 20533395
6. The impact of alpha-lipoic acid, coenzyme Q10 and caloric restriction on life span and gene expression patterns in mice. Lee CK, Pugh TD, Klopp RG, Edwards J, Allison DB, Weindruch R, Prolla TA, Free Radic Biol Med 2004 36 8 1043 1057 10.1016/j.freeradbiomed.2004.01.015 15059645 (Pubitemid 38410811)
7. Influence of Coenzyme Q-{10} on release of pro-inflammatory chemokines in the human monocytic cell line THP-1. Schmelzer C, Lorenz G, Rimbach G, Doring F, Biofactors 2007 31 3-4 211 217 10.1002/biof.5520310308 18997284
8. In Vitro Effects of the Reduced Form of Coenzyme Q(10) on Secretion Levels of TNF-alpha and Chemokines in Response to LPS in the Human Monocytic Cell Line THP-1. Schmelzer C, Lorenz G, Rimbach G, Doring F, J Clin Biochem Nutr 2009 44 1 62 66 10.3164/jcbn.08-182 19177190
9. Effects of Coenzyme Q10 on TNF-alpha secretion in human and murine monocytic cell lines. Schmelzer C, Lorenz G, Lindner I, Rimbach G, Niklowitz P, Menke T, Doring F, Biofactors 2007 31 1 35 41 10.1002/biof.5520310104 18806307 (Pubitemid 352032104)
10. Plasma membrane ubiquinone controls ceramide production and prevents cell death induced by serum withdrawal. Barroso MP, Gomez-Diaz C, Villalba JM, Buron MI, Lopez-Lluch G, Navas P, J Bioenerg Biomembr 1997 29 3 259 267 10.1023/A:1022462111175 9298711 (Pubitemid 27371727)
11. N-acetylcysteine, coenzyme Q10 and superoxide dismutase mimetic prevent mitochondrial cell dysfunction and cell death induced by d-galactosamine in primary culture of human hepatocytes. Gonzalez R, Ferrin G, Hidalgo AB, Ranchal I, Lopez-Cillero P, Santos-Gonzalez M, Lopez-Lluch G, Briceno J, Gomez MA, Poyato A, et al. Chem Biol Interact 2009 181 1 95 106 10.1016/j.cbi.2009.06.003 19523936
12. PET genes of Saccharomyces cerevisiae. Tzagoloff A, Dieckmann CL, Microbiol Rev 1990 54 3 211 225 2215420
13. The quinone-binding and catalytic site of complex II. Maklashina E, Cecchini G, Biochim Biophys Acta 1797 12 1877 1882
14. Comparison of a coq7 deletion mutant with other respiration-defective mutants in fission yeast. Miki R, Saiki R, Ozoe Y, Kawamukai M, Febs J 2008 275 21 5309 5324 10.1111/j.1742-4658.2008.06661.x 18808426
15. A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, Dimauro S, Hirano M, Am J Hum Genet 2006 78 2 345 349 10.1086/500092 16400613 (Pubitemid 43157573)
16. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Lopez LC, Schuelke M, Quinzii CM, Kanki T, Rodenburg RJ, Naini A, Dimauro S, Hirano M, Am J Hum Genet 2006 79 6 1125 1129 10.1086/510023 17186472 (Pubitemid 44853484)
17. Mutations in coenzyme Q10 biosynthetic genes. DiMauro S, Quinzii CM, Hirano M, J Clin Invest 2007 117 3 587 589 10.1172/JCI31423 17332886 (Pubitemid 46348513)
18. Ubiquinolinduced gene expression signatures are translated into altered parameters of erythropoiesis and reduced low density lipoprotein cholesterol levels in humans. Schmelzer C, Niklowitz P, Okun JG, Haas D, Menke T, Doring F, IUBMB Life 2011 63 1 42 48 10.1002/iub.413 21280176
19. PolyPhen. http://genetics.bwh.harvard.edu/pph/
20. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase). Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D, Br J Cancer 1997 75 1 69 75 10.1038/bjc.1997.11 9000600 (Pubitemid 27007275)
21. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism. Jamieson D, Wilson K, Pridgeon S, Margetts JP, Edmondson RJ, Leung HY, Knox R, Boddy AV, Clin Cancer Res 2007 13 5 1584 1590 10.1158/1078-0432. CCR-06-1416 17332305 (Pubitemid 46450451)
22. Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Vasiliou V, Ross D, Nebert DW, Hum Genomics 2006 2 5 329 335 16595077
23. Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA, Arch Neurol 67 12 1491 1497
24. APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Alvim RO, Freitas SR, Ferreira NE, Santos PC, Cunha RS, Mill JG, Krieger JE, Pereira AC, Lipids Health Dis 9 128
25. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Humphries SE, Talmud PJ, Hawe E, Bolla M, Day IN, Miller GJ, Lancet 2001 358 9276 115 119 10.1016/S0140-6736(01)05330-2 11463413 (Pubitemid 32709850)
26. Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Jofre-Monseny L, Loboda A, Wagner AE, Huebbe P, Boesch-Saadatmandi C, Jozkowicz A, Minihane AM, Dulak J, Rimbach G, Biochem Biophys Res Commun 2007 357 1 319 324 10.1016/j.bbrc.2007.03.150 17416347 (Pubitemid 46574533)
27. Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans. Dietrich M, Hu Y, Block G, Olano E, Packer L, Morrow JD, Hudes M, Abdukeyum G, Rimbach G, Minihane AM, Lipids 2005 40 4 329 334 10.1007/s11745-006-1390-4 16028714 (Pubitemid 40770942)
28. Depletion of potential A2M risk haplotype for Alzheimer's disease in longlived individuals. Flachsbart F, Caliebe A, Nothnagel M, Kleindorp R, Nikolaus S, Schreiber S, Nebel A, Eur J Hum Genet 18 1 59 61
29. Coenzyme Q10, antioxidant status and ApoE isoforms. Battino M, Giunta S, Galeazzi L, Galeazzi R, Mosca F, Santolini C, Principi F, Ferretti G, Bacchetti T, Bencivenga R, et al. Biofactors 2003 18 1-4 299 305 10.1002/biof.5520180234 14695947 (Pubitemid 38030725)
30. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC, Am J Epidemiol 2002 155 6 487 495 10.1093/aje/155.6.487 11882522 (Pubitemid 34208040)
31. Isolation and functional expression of human COQ3, a gene encoding a methyltransferase required for ubiquinone biosynthesis. Jonassen T, Clarke CF, J Biol Chem 2000 275 17 12381 12387 10.1074/jbc.275.17.12381 10777520 (Pubitemid 30241377)
32. Saccharomyces cerevisiae Coq9 polypeptide is a subunit of the mitochondrial coenzyme Q biosynthetic complex. Hsieh EJ, Gin P, Gulmezian M, Tran UC, Saiki R, Marbois BN, Clarke CF, Arch Biochem Biophys 2007 463 1 19 26 10.1016/j.abb.2007.02.016 17391640 (Pubitemid 46879701)
33. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Beyer RE, Segura-Aguilar J, Di Bernardo S, Cavazzoni M, Fato R, Fiorentini D, Galli MC, Setti M, Landi L, Lenaz G, Proc Natl Acad Sci USA 1996 93 6 2528 2532 10.1073/pnas.93.6.2528 8637908 (Pubitemid 26104381)
34. DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function. Landi L, Fiorentini D, Galli MC, Segura-Aguilar J, Beyer RE, Free Radic Biol Med 1997 22 1-2 329 335 10.1016/S0891-5849(96)00294-8 8958158 (Pubitemid 26399339)
35. Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anticancer chemotherapy. Kelsey KT, Ross D, Traver RD, Christiani DC, Zuo ZF, Spitz MR, Wang M, Xu X, Lee BK, Schwartz BS, et al. Br J Cancer 1997 76 7 852 854 10.1038/bjc.1997.474 9328142 (Pubitemid 27401934)
36. The C609T variant of NQO1 is associated with carotid artery plaques in patients with type 2 diabetes. Han SJ, Kang ES, Kim HJ, Kim SH, Chun SW, Ahn CW, Cha BS, Nam M, Lee HC, Mol Genet Metab 2009 97 1 85 90 10.1016/j.ymgme.2009.01. 012 19251446
37. Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there? Rimbach G, Minihane AM, Proc Nutr Soc 2009 68 2 162 172 10.1017/S0029665109001116 19245741
38. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Jofre-Monseny L, Minihane AM, Rimbach G, Mol Nutr Food Res 2008 52 1 131 145 10.1002/mnfr.200700322 18203129 (Pubitemid 351211806)